Small cell lung cancer tumour cells induce regulatory T lymphocytes, and patient survival correlates negatively with FOXP3+ cells in tumour infiltrate

Inhibition of Tumor Growth by NK1.1+ Cells and CD8+ T Cells Activated by IL-15 through Receptor  /Common   Signaling in trans

(2014) J. Rowley et al.   JOURNAL OF IMMUNOLOGY

FOXP3 and survival in urinary bladder cancer

(2011) Malin E. Winerdal et al.   BJU INTERNATIONAL

Interleukin 15 as a promising candidate for tumor immunotherapy

(2011) Marek Jakobisiak et al.   CYTOKINE & GROWTH FACTOR REVIEWS

Both CD4+ FoxP3+ and CD4+ FoxP3− T cells from patients with B-cell malignancy express cytolytic markers and kill autologous leukaemic B cells in vitro

(2011) Camilla A. Lindqvist et al.   IMMUNOLOGY

Expression of Helios in Peripherally Induced Foxp3+ Regulatory T Cells

(2011) R. A. Gottschalk et al.   JOURNAL OF IMMUNOLOGY

Helios Expression Is a Marker of T Cell Activation and Proliferation

(2011) Tatiana Akimova et al.   PLoS One

Clinical impact of tumor-infiltrating lymphocytes for survival in stage II colon cancer

(2010) Won-Suk Lee et al.   CANCER

Induction of tumor-specific acquired immunity against already established tumors by selective stimulation of innate DEC-205+ dendritic cells

(2010) Keiichi Moriya et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

CD8+ Enriched "Young" Tumor Infiltrating Lymphocytes Can Mediate Regression of Metastatic Melanoma

(2010) M. E. Dudley et al.   CLINICAL CANCER RESEARCH

Androgen Deprivation Boosts Prostatic Infiltration of Cytotoxic and Regulatory T Lymphocytes and Has No Effect on Disease-Free Survival in Prostate Cancer Patients

(2010) Carlo Sorrentino et al.   CLINICAL CANCER RESEARCH

A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer

(2010) Melissa A. Geller et al.   CYTOTHERAPY

Higher intratumoral infiltrated Foxp3+ Treg numbers and Foxp3+/CD8+ ratio are associated with adverse prognosis in resectable gastric cancer

(2010) Zhengbin Shen et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Expression of Helios, an Ikaros Transcription Factor Family Member, Differentiates Thymic-Derived from Peripherally Induced Foxp3+ T Regulatory Cells

(2010) A. M. Thornton et al.   JOURNAL OF IMMUNOLOGY

Regulatory (FoxP3+) T-cell Tumor Infiltration Is a Favorable Prognostic Factor in Advanced Colon Cancer Patients Undergoing Chemo or Chemoimmunotherapy

(2010) Pierpaolo Correale et al.   JOURNAL OF IMMUNOTHERAPY

FOXP3+ Cell Density in Primary Tumor Has No Prognostic Impact in Patients with Cutaneous Malignant Melanoma

(2010) Andrea Ladányi et al.   PATHOLOGY & ONCOLOGY RESEARCH

Natural antibodies, intravenous immunoglobulin and their role in autoimmunity, cancer and inflammation

(2009) R. Schwartz-Albiez et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

IL-15 promotes regulatory T cell function and protects against diabetes development in NK-depleted NOD mice

(2009) Jinxing Xia et al.   CLINICAL IMMUNOLOGY

Plasticity of CD4+ T Cell Lineage Differentiation

(2009) Liang Zhou et al.   IMMUNITY

Cutting Edge: TGF- 1 and IL-15 Induce FOXP3+    Regulatory T Cells in the Presence of Antigen Stimulation

(2009) R. Casetti et al.   JOURNAL OF IMMUNOLOGY

Twenty-Seven Years of Phase III Trials for Patients with Extensive Disease Small-Cell Lung Cancer: Disappointing Results

(2009) Isao Oze et al.   PLoS One

Clinical applications of natural killer T cell–based immunotherapy for cancer

(2008) Shinichiro Motohashi et al.   CANCER SCIENCE

Non-AIDS-defining cancers

(2008) Justin Stebbing et al.   CURRENT OPINION IN INFECTIOUS DISEASES

IL-15 acts as a potent inducer of CD4+CD25hi cells expressing FOXP3

(2008) Hiromi Imamichi et al.   EUROPEAN JOURNAL OF IMMUNOLOGY